COVERED by most public formularies and private insurance plans1–9
PrREXULTI® is also covered as a general benefit by the NIHB, CSC, and VAC13–15
In QC, patient’s eligibility for reimbursement of REXULTI through the RAMQ Patient d’exception program will need to be assessed*
CSC: Correctional Service Canada; NIHB: Non-Insured Health Benefits; VAC: Veterans Affairs Canada.
* RAMQ is the Official Mark of the Régie de l’assurance maladie du Québec.
References: 1. Alberta Health. Drug benefit list. April 1, 2021. 2. Manitoba Pharmacare. Formulary Search Results. December 1, 2021. 3. Ontario Drug Benefit. Formulary. February 26, 2021. 4. New Brunswick Drug Plan Bulletin #1087. September 26, 2022. 5. Nova Scotia Formulary Pharmacare News. September 2022. 6. Newfoundland and Labrador. Benefit List update. May 12, 2022. 7. Northwest Territories. Data on File, NWT. November 17, 2020. 8. Health PEI. PEI Pharmacare Bulletin. November 16, 2022. 9. REXULTI. Data on File. Private coverage plan. 10. British Columbia PharmaCare. Formulary Search Results. November 23, 2021. 11. Saskatchewan Drug Plan. Exception Drug Status Program (Appendix A). November 30, 2021. 12. Yukon. Formulary Search Results. December 1, 2021. 13. Data on File, Otsuka Pharmaceutical Co., Ltd. 2019. NIHB coverage. 14. Correctional Service Canada. Data on File. August 2019. 15. Veterans Affairs Canada. Formulary Search Results. November 2, 2021.